FDA Approved: ERGOMAR SUBLINGUAL — Supplemental Application (Pangea Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for ERGOMAR SUBLINGUAL containing ergotamine tartrate, manufactured by Pangea Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• ERGOMAR SUBLINGUAL (ERGOTAMINE TARTRATE)

Snippet

SUPPL AP for ERGOMAR SUBLINGUAL (ERGOTAMINE TARTRATE)